Humana (HUM) stock rebounds after earnings shock — Star Ratings and Medicare rates now drive the price
Humana shares rose 1.96% to $178.83, breaking a three-day slide, as volume surged above average despite broader market losses. The company reported a Q4 GAAP loss of $6.61 per share and projected 2026 adjusted EPS of at least $9, well below analyst estimates. RBC Capital and other firms cut price targets after Humana warned lower Medicare Advantage Star Ratings would reduce profits by $3.5 billion.